摘要
肺炎支原体作为呼吸道感染的重要病原,不但可引起原发性非典型性肺炎,而且可引起全身器官的病变。肺炎支原体是学龄儿童呼吸道感染重要病原体之一,亦是成年人呼吸道感染不可忽视的致病原。深入研究肺炎支原体感染对其机体免疫作用对于开发靶向治疗药物具有重要意义,而对其流行病学和发病症状的研究有助于临床的预防和诊断,对于不同个体采取不同药物治疗的个体化治疗亦有重要意义。本文针对近年来肺炎支原体研究现状,针对以上三点加以综述。
Mycoplasma pneumoniae is an major pathogen associated with respiratory infections. The pathogen causes primary atypical pneumonia as well as systemic organ lesions. M. pneumonia is a major cause of respiratory infections in schoolchildren and is also responsible for respiratory tract infections in adults. Further study of the body＇s immune response to M. pneumoniae infection is crucial to the development of targeted drugs. Study of the epidemiology of M. pneumoniae and its symptoms will help with its clinical prevention and diagnosis. Personalized treatment with specific medications for certain individuals is also vital. This paper summarizes the current research on M. pneumoniae and reviews it in terms of these 3 aspects.
出处
《中国病原生物学杂志》
CSCD
北大核心
2013年第5期473-475,480,共4页
Journal of Pathogen Biology
关键词
肺炎支原体
感染
治疗
免疫反应
综述
Mycoplasma pneumoniae
infection
treatment
immune response
review
作者简介
【通讯作者（简介）】陈开革（1977-），男，广西梧州人，学士，主管药师。研究方向：医院药学。E—mail：wgpghn@163．com
